Dean Capital Investments Management LLC reduced its stake in shares of Danaher Co. (NYSE:DHR) by 10.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,413 shares of the conglomerate’s stock after selling 491 shares during the quarter. Dean Capital Investments Management LLC’s holdings in Danaher were worth $637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Howe & Rusling Inc. grew its holdings in shares of Danaher by 116.3% in the third quarter. Howe & Rusling Inc. now owns 186 shares of the conglomerate’s stock valued at $27,000 after purchasing an additional 100 shares in the last quarter. Next Capital Management LLC bought a new stake in shares of Danaher during the second quarter worth $31,000. Litman Gregory Asset Management LLC bought a new stake in shares of Danaher during the second quarter worth $33,000. Altshuler Shaham Ltd lifted its position in shares of Danaher by 59.3% during the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 89 shares during the last quarter. Finally, Pinnacle Bank lifted its position in shares of Danaher by 52.3% during the third quarter. Pinnacle Bank now owns 262 shares of the conglomerate’s stock worth $38,000 after purchasing an additional 90 shares during the last quarter. 78.40% of the stock is owned by institutional investors and hedge funds.
In other news, Chairman Mitchell P. Rales acquired 2,500 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was purchased at an average cost of $139.52 per share, for a total transaction of $348,800.00. Following the completion of the acquisition, the chairman now directly owns 3,030,453 shares of the company’s stock, valued at approximately $422,808,802.56. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.40% of the company’s stock.
Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.01. The firm had revenue of $5.04 billion during the quarter, compared to the consensus estimate of $5.02 billion. Danaher had a return on equity of 11.42% and a net margin of 12.13%. The firm’s quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.10 earnings per share. Equities research analysts expect that Danaher Co. will post 4.76 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.17 dividend. The ex-dividend date of this dividend was Thursday, September 26th. This represents a $0.68 annualized dividend and a dividend yield of 0.50%. Danaher’s payout ratio is currently 15.04%.
Several research firms have recently weighed in on DHR. Argus lifted their target price on Danaher to $165.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Robert W. Baird lifted their target price on Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Royal Bank of Canada set a $134.00 target price on Danaher and gave the stock a “hold” rating in a research report on Friday, July 19th. Wolfe Research set a $154.00 target price on Danaher and gave the stock a “buy” rating in a research report on Friday, October 25th. Finally, Credit Suisse Group reiterated an “outperform” rating and set a $151.00 target price on shares of Danaher in a research report on Monday, October 14th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $145.86.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: Roth IRA
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.